Silodosin and Ningmitai for enlarged prostate symptom relief
Treatments studied
Part of Kidney & urinary clinical trials.
This trial studies whether silodosin alone or combined with Ningmitai capsules can safely improve urinary symptoms from an enlarged prostate (BPH). It may help men with bothersome, measurable urination problems, while carefully excluding conditions that could mimic or complicate BPH.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 60 to 80 with a doctor-diagnosed enlarged prostate (BPH)
- Your symptom score (IPSS) is at least 8 when first screened and at the start
- Your urine flow rate is in a specific range, and ultrasound shows your prostate is at least 30 mL
- You can read and understand the study forms/questionnaires and agree to sign consent
- You have no prostate cancer or other cancer tumors
- You have no major urine/passing problems from other causes (like bladder blockage, infection, stones, or retention needing treatment)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, once-daily tablet (H077) compared to the standard medicine silodosin for treating symptoms of an enlarged prostate. It aims to see if the new medicine works as well and is safe.
This trial tests whether a two-in-one pill can reduce the frequent and urgent need to pee caused by an enlarged prostate. It's for men who have had these symptoms for at least 3 months.
This study tests a new, minimally invasive procedure to relieve urinary symptoms caused by an enlarged prostate (benign prostatic hyperplasia or BPH). The procedure gently dilates (widens) the prostate to improve urine flow and reduce bothersome symptoms like frequent urination and weak stream.
This trial compares two medications, silodosin and tamsulosin, to see which one works better for men with frequent or difficult urination caused by an enlarged prostate. All participants will try both medicines at different times to find the best option.
This trial tests how a medication called silodosin (8 mg once daily) affects symptoms and ejaculatory function in men with an enlarged prostate causing urinary problems. It aims to understand both the benefits and side effects of this treatment.
This study tests whether taking tadalafil (at 2.5 mg or 5 mg) along with tamsulosin is better for treating urinary symptoms caused by an enlarged prostate than taking tamsulosin alone. It aims to find the best dose combination to improve your quality of life.
Hear when a new Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.